Experiences of Healthcare for Autistic TGD Adults
Not yet recruiting
- Conditions
- Autism Spectrum Disorder (ASD
- Registration Number
- NCT06850948
- Lead Sponsor
- University of Nottingham
- Brief Summary
To explore the experiences of autistic gender diverse adults that have attempted or are attempting to access, have accessed or are currently accessing gender identity healthcare in the United Kingdom
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
- Participants must be 18 years or older, they must have first-hand experiences of currently accessing, previously having accessed, or having attempted to access NHS Gender identity clinics in the United Kingdom. The participant must identify as TGD in some capacity (e.g. transgender, nonbinary) and have a formal diagnosis of autism. (Proof of formal diagnosis will not be sought, but participants will be asked about information on this. Diagnosis of autism be asked on the demographic questionnaire, along with question on the diagnosis procedure (e.g. service diagnosis, age of diagnosis). The participant must be able to communicate (verbal or written) in the English Language and be able to provide informed consent.
Exclusion Criteria
- People who do not meet the inclusion criteria will be excluded from the research.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Interview From March 2025 to September 2026 Qualitative interview
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What biomarkers correlate with healthcare access barriers in autistic transgender adults?
How do gender-affirming interventions compare in efficacy for autistic versus neurotypical TGD populations?
What adverse events are reported in ASD TGD adults during gender transition healthcare processes?
How do neurobiological mechanisms of ASD intersect with gender identity development in clinical populations?
What combination therapies improve healthcare outcomes for autistic gender diverse individuals in the UK?